{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "39-year-old never smoker Caucasian woman presented with gradual onset of dyspnoea, cough and left-sided pleuritic pain over the last 3 months.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "39-year-old Caucasian woman presented with gradual onset of dyspnoea, cough and left-sided pleuritic pain over the last 3 months.",
              "duration": "P3M",
              "onset": null,
              "progression": "gradual",
              "associated_symptoms": [
                "C0013404",
                "C0010200",
                "C0231759"
              ]
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "never",
              "description": "never smoker"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Thorax CT showed the presence of a 52\u00d761\u00d762-mm mass in the left upper lobe of the lung.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "52\u00d761\u00d762-mm mass in the left upper lobe",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Stage IV adenocarcinoma of the lung with bone, liver and left adrenal distant metastases.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Adenocarcinoma of lung",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C79.51",
              "label": "Metastatic bone cancer",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C78.7",
              "label": "Secondary malignant neoplasm of liver",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C79.70",
              "label": "Secondary malignant neoplasm of adrenal gland, unspecified",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Molecular analysis of the lung biopsy detected an EML4-ALK translocation via fluorescent in situ hybridisation.",
        "clinical_data": {
          "labs": [
            {
              "test": "Fluorescent in situ hybridization",
              "finding": "EML4-ALK translocation",
              "body_part": "Lung"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient was given crizotinib, resulting in a partial response in the lung primary tumour and stable disease at the metastatic sites after 5 months of therapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974219",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0006826"
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "metastatic sites",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "9 months from crizotinib initiation, the patient progressed with an increase in the number and size of the liver metastases. Crizotinib was discontinued.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0886434",
              "end_date": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0239144",
              "label": "Liver Metastases",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient was given ceritinib followed by alectinib successively.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C3217025",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C3651301",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient received six cycles of carboplatin and pemetrexed, resulting in short-term disease stabilisation.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007127",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0974094",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "disease stabilisation",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Repeat biopsy of the liver metastasis revealed a G to A point mutation in exon 23 of the ALK gene, resulting in G1202R substitution of the ALK tyrosine kinase receptor, using Ion AmpliSeq Targeted Sequencing Technology.",
        "clinical_data": {
          "labs": [
            {
              "test": "ALK gene mutation analysis",
              "value": "G to A point mutation in exon 23, resulting in G1202R substitution",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ],
          "imaging": [
            {
              "type": "Liver metastasis",
              "body_part": "Liver",
              "modality": "Biopsy",
              "finding": "ALK gene mutation",
              "impression": "ALK gene mutation",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Patient was then given lorlatinib. Treatment with lorlatinib delayed disease progression for 5 months.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1608544",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "disease progression",
              "status": null,
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Plasma was sent for circulating-free tumour DNA (cfDNA) analysis.",
        "clinical_data": {
          "labs": [
            {
              "test": "Circulating free tumor DNA analysis",
              "value": null,
              "unit": null,
              "flag": null,
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "cfDNA analysis revealed ALK G1269A point mutation (3.5% reads), ongoing presence of G1202R mutation (14.5%), and variant 3a/b EML4(6)-ALK(20) translocation.",
        "clinical_data": {
          "labs": [
            {
              "test": "cfDNA analysis",
              "value": "ALK G1269A point mutation (3.5% reads), ongoing presence of G1202R mutation (14.5%), and variant 3a/b EML4(6)-ALK(20) translocation",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "ALK G1269A point mutation",
              "status": "active",
              "onset_date": null
            },
            {
              "code": null,
              "label": "G1202R mutation",
              "status": "active",
              "onset_date": null
            },
            {
              "code": null,
              "label": "variant 3a/b EML4(6)-ALK(20) translocation",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "Repeat liquid biopsy a month later showed no differences in cfDNA analysis.",
        "clinical_data": {
          "labs": [
            {
              "test": "Liquid Biopsy",
              "value": "no differences in cfDNA analysis",
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "Patient succumbed to her disease.",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Initial presentation of dyspnoea, cough, and pleuritic pain, leading to further investigation via thorax CT.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0013404",
            "C0010200",
            "C0231759"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "CT scan revealing a lung mass, leading to diagnosis of Stage IV adenocarcinoma with metastases.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Diagnosis of Stage IV adenocarcinoma prompting molecular analysis of lung biopsy.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C34.9",
            "C79.51",
            "C78.7",
            "C79.70"
          ],
          "change_type": "other",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Detection of EML4-ALK translocation leading to crizotinib treatment and partial response.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974219"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Crizotinib treatment followed by disease progression with liver metastases, leading to discontinuation of crizotinib.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C0239144"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Progression on crizotinib leading to initiation of ceritinib followed by alectinib.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C3217025",
            "C3651301"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Treatment with ceritinib and alectinib followed by carboplatin and pemetrexed, resulting in short-term disease stabilisation.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0007127",
            "C0974094"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Disease stabilisation followed by repeat biopsy of liver metastasis.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": []
        }
      }
    }
  ]
}